RESUMO
As a result of population growth and the development of tube wells, humans' exposure to arsenic has increased over the past few decades. The natural course of organ damage secondary to arsenic exposure is not yet well understood. In Toroku, Japan, an arsenic mine was intermittently operated from 1920 to 1962, and residents were exposed to high concentrations of arsenic. In this paper, we analyzed 190 consecutive residents for whom detailed records of neurological symptoms and findings were obtained from 1974 to 2005. All participants were interviewed regarding the presence of general, skin, hearing, respiratory, and neurological symptoms. Neurological symptoms were classified into extremity numbness or pain, constipation, dyshidrosis, sensory loss, and muscle atrophy. Superficial and vibratory sensation was also evaluated. More than 80% of participants experienced extremity numbness, and numbness was the most common neurological symptom. Numbness was associated with superficial sensory disturbance, and was correlated with the subsequent development of other neurological symptoms, including autonomic and motor symptoms. No previous studies have investigated the natural course of chronic arsenic intoxication; thus, these data serve as a guide for detecting early symptoms due to arsenic exposure.
Assuntos
Intoxicação por Arsênico , Arsênio , Arsênio/toxicidade , Intoxicação por Arsênico/epidemiologia , Humanos , Japão/epidemiologiaRESUMO
Chorea is thought to be caused by deactivation of the indirect pathway in the basal ganglia circuit. However, few imaging studies have evaluated the basal ganglia circuit in actual patients with chorea. We investigated the lesions and mechanisms underlying chorea using brain magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). This retrospective case series included three patients with chorea caused by different diseases: hyperglycemic chorea, Huntington's disease, and subarachnoid hemorrhage. All the patients showed dysfunction in the striatum detected by both MRI and FDG-PET. These neuroimaging findings confirm the theory that chorea is related to an impairment of the indirect pathway of basal ganglia circuit.
RESUMO
Chronic arsenic intoxication is known to cause multisystem impairment and is still a major threat to public health in many countries. In Toroku, a small village in Japan, arsenic mines operated from 1920 to 1962, and residents suffered serious sequelae of arsenic intoxication. We have performed annual medical examinations of these residents since 1974, allowing us to characterize participants' long-term health following their last exposure to arsenic. The participants could not be described as having "chronic arsenic intoxication," because their blood arsenic levels were not measured. In this study, we defined them as having "probable arsenic intoxication." Symptoms frequently involved the sensory nervous system, skin, and upper respiratory system (89.1-97.8%). In an analysis of neurological findings, sensory neuropathy was common, and more than half of the participants complained of hearing impairment. Longitudinal assessment with neurological examinations and nerve conduction studies revealed that sensory dysfunction gradually worsened, even after exposure cessation. However, we could not conclude that arsenic caused the long-term decline of sensory function due to a lack of comparisons with age-matched healthy controls. This is the first study to characterize the longitudinal sequelae after probable arsenic exposure. Our study will be helpful to assess the prognosis of patients worldwide who still suffer from chronic arsenic intoxication.
Assuntos
Intoxicação por Arsênico/etiologia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Feminino , Perda Auditiva/induzido quimicamente , Perda Auditiva/etiologia , Humanos , Lactente , Japão , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Mineração , Polineuropatias/induzido quimicamente , Polineuropatias/etiologiaRESUMO
A 50-year-old man with a family history of stroke and depression slowly developed brain lesions. Magnetic resonance imaging revealed hyperintense lesions in the diffuse white matter, external capsules, and temporal poles on T2-weighted imaging. A heterozygous mutation c.3879C>G in exon 24 of the NOTCH3 gene (p.Cys1293Trp) was detected, confirming a diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Exon 24 mutations are rather rare and this represents the first Japanese case of CADASIL.
Assuntos
CADASIL/diagnóstico , CADASIL/genética , Mutação , Receptor Notch3/genética , Acidente Vascular Cerebral/genética , Idoso , Povo Asiático , Éxons , Feminino , Genótipo , Heterozigoto , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , FenótipoRESUMO
BACKGROUND: Apolipoprotein E (apoE) is closely involved in the pathogenesis of apoE-related diseases, such as Alzheimer's disease and cardiovascular disease. The redox modulation of cysteine-thiols in a protein is involved in various pathophysiological regulations; however, that of apoE has not been studied in detail. Herein, we devised an analytical method to determine the redox status of serum apoE and assessed its relation to serum cholesterol levels and apoE phenotype. METHODS: The present method was based on a band shift assay, using a photocleavable maleimide-conjugated polyethylene glycol. RESULTS: The basic characteristics of the present method were found to be satisfactory to determine the redox status of serum apoE quantitatively. Serum apoE was separated into its reduced-form (r-), non-reduced-form (nr-), apoE-AII complex, and homodimer using this method. R-apoE could be detected as a 40-kDa band, whereas nr-apoE remained as monomeric apoE. R-apoE displayed a preference for VLDL; however, the levels showed the correlation with HDL-cholesterol levels (p<0.005). Redox status of serum apoE was significantly different among apoE phenotypes. The quantitative ratios of nr-apoE to total apoE in serum from subjects with apoE4/E3 were higher than in serum from subjects with apoE3/E3 (p<0.0001) and apoE3/E2 (p<0.001). CONCLUSION: The redox status of serum apoE might be related to the synthesis of HDL. The information concerning the redox status of serum apoE provided by the present method may be a potent indicator to evaluate various apoE-related diseases.
Assuntos
Apolipoproteínas E/sangue , HDL-Colesterol/sangue , Apolipoproteína A-II/sangue , Apolipoproteína A-II/química , Apolipoproteína A-II/isolamento & purificação , Apolipoproteína E2/sangue , Apolipoproteína E2/química , Apolipoproteína E2/isolamento & purificação , Apolipoproteína E3/sangue , Apolipoproteína E3/química , Apolipoproteína E3/isolamento & purificação , Apolipoproteína E4/sangue , Apolipoproteína E4/química , Apolipoproteína E4/isolamento & purificação , Apolipoproteínas E/química , Apolipoproteínas E/isolamento & purificação , HDL-Colesterol/química , Cisteína/química , Diamida/química , Dimerização , Ditiotreitol/química , Ensaio de Desvio de Mobilidade Eletroforética , Células HEK293 , Humanos , Indicadores e Reagentes/química , Peso Molecular , Oxirredução , Processos Fotoquímicos , Polietilenoglicóis/química , Solubilidade , Reagentes de Sulfidrila/química , Raios UltravioletaRESUMO
Case 1: A 66-year-old man was admitted because of progressive gait disturbance and dysphagia after developing red rash. He was diagnosed as Guillain-Barré syndrome (GBS) and treated by intravenous immunoglobulin therapy (IVIg). Two weeks later, he could swallow and walk without any abnormalities. Case 2: A 58-year-old woman was admitted because of gait disturbance, bilateral peripheral facial nerve palsies, and respiratory failure one week after developing fever and rash. She was diagnosed as GBS and treated with IVIg. She underwent mechanical ventilation, while she could wean off it one month later and her limb strengths improved. We confirmed both patients had scrub typhus by serological studies. Peripheral neuropathy is one of the complications of scrub typhus. In addition, this disease sometimes leads to severe GBS. GBS should be included in differential diagnosis when peripheral neuropathies develop in the course of treating scrub typhus, and we should keep in mind that scrub typhus is one of the causes of GBS.
Assuntos
Síndrome de Guillain-Barré/etiologia , Tifo por Ácaros/complicações , Idoso , Anticorpos Antibacterianos/sangue , Biomarcadores/sangue , Diagnóstico Diferencial , Feminino , Síndrome de Guillain-Barré/tratamento farmacológico , Humanos , Imunoglobulinas Intravenosas/administração & dosagem , Masculino , Pessoa de Meia-Idade , Orientia tsutsugamushi/imunologia , Tifo por Ácaros/diagnóstico , Testes Sorológicos , Índice de Gravidade de DoençaRESUMO
BACKGROUND: The association between Parkinson's disease (PD) and body mass index (BMI) has not been established. In this study, we investigated the correlation between BMI and autonomic dysfunction in patients with PD. METHODS: Clinical features, BMI, cardiac (123)I-metaiodobenzylguanidine (MIBG) scintigraphy and the coefficient of variation of the electrocardiographic R-R interval (CVRR) were analyzed in 124 patients with PD who were naïve to anti-parkinsonian drugs. RESULTS: BMI was negatively correlated with early heart-to-mediastinum ratio and CVRR in patients with PD, regardless of disease duration and severity. CONCLUSIONS: Autonomic dysfunction and BMI increase were associated with each other. Physicians should consider the possibility of autonomic dysfunction in PD patients with high BMI.
Assuntos
Doenças do Sistema Nervoso Autônomo/etiologia , Índice de Massa Corporal , Doença de Parkinson/complicações , 3-Iodobenzilguanidina/farmacocinética , Idoso , Doenças do Sistema Nervoso Autônomo/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/diagnóstico por imagem , Compostos Radiofarmacêuticos/farmacocinética , Estudos RetrospectivosRESUMO
BACKGROUND: Cardiac 123I-metaiodobenzylguanidine scintigraphy (MIBG) previously demonstrated an uptake reduction in patients with Parkinson's disease (PD). However, epidemiologic research showed that electrocardiography (ECG) abnormalities occurred prior to motor signs in PD. Here we investigated whether the electrical conduction system of the heart was impaired in PD. METHODS: Clinical features, ECG and MIBG parameters were analyzed in 191 patients with PD, 42 with multiple system atrophy (MSA) and 124 normal controls (NL). RESULTS: The PR interval was significantly longer in patients with PD than in NL. The PR interval was significantly negatively correlated with early and delayed heart-to-mediastinum ratios in MIBG scintigraphy in PD and MSA patients. In 19 PD patients with PR prolongation, 17 patients also had abnormal MIBG findings, and the other 2 showed normal MIBG. CONCLUSIONS: The PR prolongation must show some sympathetic system abnormality because it is mainly controlled by the sympathetic nervous system. PR prolongation supports the objective biomarker value of MIBG for PD diagnosis.
Assuntos
Arritmias Cardíacas/diagnóstico por imagem , Sistema de Condução Cardíaco/anormalidades , Doença de Parkinson/complicações , Doença de Parkinson/diagnóstico por imagem , 3-Iodobenzilguanidina , Idoso , Arritmias Cardíacas/etiologia , Síndrome de Brugada , Doença do Sistema de Condução Cardíaco , Eletrocardiografia , Feminino , Sistema de Condução Cardíaco/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Imagem de Perfusão do Miocárdio/métodos , Compostos RadiofarmacêuticosRESUMO
In previous studies of human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), areas of slow blood flow in the spinal cord were related to pathological changes. While the pathological changes in the brain are milder than those in the spinal cord, they are also more significant in sites with slow blood flow. In this study, we investigated brain glucose metabolism in slow blood flow areas using fluorine-18 fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET). Clinical features and brain (18)F-FDG-PET parameters were analyzed in six patients with HAM/TSP. For comparison of PET data, eight healthy volunteers were enrolled as normal controls (NLs). Glucose metabolism in the watershed areas of the middle and posterior cerebral arteries, as compared with that in the occipital lobes as a control, was significantly lower in HAM/TSP patients than in NLs. This result confirmed the relationship between slow blood flow areas and hypometabolism in HAM/TSP, and is consistent with previous findings that pathological changes are accentuated in sites with slow blood flow.
Assuntos
Encéfalo/metabolismo , Glucose/metabolismo , Paraparesia Espástica Tropical/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Velocidade do Fluxo Sanguíneo/fisiologia , Encéfalo/diagnóstico por imagem , Artérias Cerebrais/metabolismo , Circulação Cerebrovascular/fisiologia , Feminino , Fluordesoxiglucose F18 , Humanos , Masculino , Pessoa de Meia-Idade , Imagem Multimodal , Paraparesia Espástica Tropical/diagnóstico , Paraparesia Espástica Tropical/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos , Fluxo Sanguíneo Regional/fisiologia , Estudos Retrospectivos , Tomografia Computadorizada por Raios XRESUMO
A 64-year-old woman with diffuse large B-cell Lymphoma (DLBCL) complained of double vision and pain sensation in her limbs after eight cycles of chemotherapy. F-fluorodexyglucose-positron emission tomography (FDG-PET) 7 days after the onset of double vision showed no abnormal accumulation and confirmed remission of DLBCL according to the international criteria. However, she developed limb weakness and severe paresthesia. The second FDG-PET 41 days after onset showed increased uptake at the both the brachial and lumbar plexuses, suggesting neurolymphomatosis. Although FDG-PET appears to be a highly sensitive diagnostic method for neurolymphomatosis, it is sometimes difficult to detect neurolymphomatosis in early diagnose, such as with this case. Therefore, multiple examinations are necessary to determine neurolymphomatosis.